FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Michael Bell

Research Profile

Living Beings

Genes & Molecular Sequences

Amino Acid Sequences

Chemicals & Drugs

Concepts & Ideas

Anatomy

Physiology

Procedures

Cloning, Molecular

Co-author Network

Publications

TOP 3
Kevin Pavelko; Kathleen S Allen; Michael P Bell; Michael J Hansen; Lavakumar Karyampudi; Keith L Knutson; Larry R Pease
The epitope integration site for vaccine antigens determines virus control while maintaining efficacy in an engineered cancer vaccine.
Kevin Pavelko; Moses Rodriguez; Michael P Bell; Chella S David; Michael J Hansen; Aaron J Johnson; Yanice V Mendez-Fernandez; Larry R Pease
Nonequivalence of classical MHC class I loci in ability to direct effective antiviral immunity.
Kevin Pavelko; Megan A Girtman; Yoshihiro Mitsunaga; Yanice V Mendez-Fernandez; Michael P Bell; Michael J Hansen; Kathleen S Allen; Moses Rodriguez; Larry R Pease
Theiler's murine encephalomyelitis virus as a vaccine candidate for immunotherapy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Michael Bell (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Kevin Pavelko; Kathleen S Allen; Michael P Bell; Michael J Hansen; Lavakumar Karyampudi; Keith L Knutson; Larry R Pease
The epitope integration site for vaccine antigens determines virus control while maintaining efficacy in an engineered cancer vaccine.
Molecular therapy : the journal of the American Society of Gene Therapy 2013;21(5):1087-95.
2012: Kevin Pavelko; Moses Rodriguez; Michael P Bell; Chella S David; Michael J Hansen; Aaron J Johnson; Yanice V Mendez-Fernandez; Larry R Pease
Nonequivalence of classical MHC class I loci in ability to direct effective antiviral immunity.
PLoS pathogens 2012;8(2):e1002541.
2011: Kevin Pavelko; Megan A Girtman; Yoshihiro Mitsunaga; Yanice V Mendez-Fernandez; Michael P Bell; Michael J Hansen; Kathleen S Allen; Moses Rodriguez; Larry R Pease
Theiler's murine encephalomyelitis virus as a vaccine candidate for immunotherapy.
PloS one 2011;6(5):e20217.
2010: Meher K Rahman; Emilie H Midtling; Phyllis A Svingen; Yuning Xiong; Michael P Bell; Jeanne Tung; Tom Smyrk; Larry J Egan; William A Faubion
The pathogen recognition receptor NOD2 regulates human FOXP3+ T cell survival.
Journal of immunology (Baltimore, Md. : 1950) 2010;184(12):7247-56.
2008: Karin L Heckman; Suresh Radhakrishnan; Tobias Peikert; Koji Iijima; Hugh C McGregor; Michael P Bell; Hirohito Kita; Larry R Pease
T-bet expression by dendritic cells is required for the repolarization of allergic airway inflammation.
European journal of immunology 2008;38(9):2464-74.
2008: Suresh Radhakrishnan; Rosalyn Cabrera; Erin L Schenk; Pilar Nava-Parada; Michael P Bell; Virginia Van Keulen; Ronald J Marler; Sara J Felts; Larry R Pease
Reprogrammed FoxP3+ T regulatory cells become IL-17+ antigen-specific autoimmune effectors in vitro and in vivo.
Journal of immunology (Baltimore, Md. : 1950) 2008;181(5):3137-47.
2007: Michael P Bell; Phyllis A Svingen; Meher K Rahman; Yuning Xiong; William A Faubion
FOXP3 regulates TLR10 expression in human T regulatory cells.
Journal of immunology (Baltimore, Md. : 1950) 2007;179(3):1893-900.
2006: Daniel B Graham; Michael P Bell; Catherine J Huntoon; Matthew D Griffin; Xuguang Tai; Alfred Singer; David J McKean
CD28 ligation costimulates cell death but not maturation of double-positive thymocytes due to defective ERK MAPK signaling.
Journal of immunology (Baltimore, Md. : 1950) 2006;177(9):6098-107.
2006: Daniel B Graham; Michael P Bell; Megan M McCausland; Catherine J Huntoon; Jan M A van Deursen; William A Faubion; Shane Crotty; David J McKean
Ly9 (CD229)-deficient mice exhibit T cell defects yet do not share several phenotypic characteristics associated with SLAM- and SAP-deficient mice.
Journal of immunology (Baltimore, Md. : 1950) 2006;176(1):291-300.
2005: Daniel B Graham; Michael P Bell; Catherine J Huntoon; Joel G R Weaver; Nanci Hawley; andrew badley; David J McKean
Increased thymic output in HIV-negative patients after antiretroviral therapy.
AIDS (London, England) 2005;19(14):1467-72.
2001: Michael P Bell; Catherine J Huntoon; D Graham; David J McKean
The analysis of costimulatory receptor signaling cascades in normal T lymphocytes using in vitro gene transfer and reporter gene analysis.
Nature medicine 2001;7(10):1155-8.
2001: David J McKean; Catherine J Huntoon; Michael P Bell; X Tai; Susan O Sharrow; KE Hedin; A Conley; Alfred Singer
Maturation versus death of developing double-positive thymocytes reflects competing effects on Bcl-2 expression and can be regulated by the intensity of CD28 costimulation.
Journal of immunology (Baltimore, Md. : 1950) 2001;166(5):3468-75.
1999: Laurence J Egan; Dennis C Mays; Catherine J Huntoon; Michael P Bell; MG Pike; William J Sandborn; James J Lipsky; David J McKean
Inhibition of interleukin-1-stimulated NF-kappaB RelA/p65 phosphorylation by mesalamine is accompanied by decreased transcriptional activity.
The Journal of biological chemistry 1999;274(37):26448-53.
1999: KE Hedin; Michael P Bell; Catherine J Huntoon; Larry M Karnitz; David J McKean
Gi proteins use a novel beta gamma- and Ras-independent pathway to activate extracellular signal-regulated kinase and mobilize AP-1 transcription factors in Jurkat T lymphocytes.
The Journal of biological chemistry 1999;274(28):19992-20001.
1997: KE Hedin; Michael P Bell; K R Kalli; Catherine J Huntoon; Burt Sharp; David J McKean
Delta-opioid receptors expressed by Jurkat T cells enhance IL-2 secretion by increasing AP-1 complexes and activity of the NF-AT/AP-1-binding promoter element.
Journal of immunology (Baltimore, Md. : 1950) 1997;159(11):5431-40.
1994: K L Schreiber; Michael P Bell; Catherine J Huntoon; S Rajagopalan; M B Brenner; David J McKean
Class II histocompatibility molecules associate with calnexin during assembly in the endoplasmic reticulum.
International immunology 1994;6(1):101-11.
1993: David J McKean; R P Podzorski; Michael P Bell; A E Nilson; Catherine J Huntoon; J Slack; S K Dower; J Sims
Murine T helper cell-2 lymphocytes express type I and type II IL-1 receptors, but only the type I receptor mediates costimulatory activity.
Journal of immunology (Baltimore, Md. : 1950) 1993;151(7):3500-10.
1992: Larry M Karnitz; S L Sutor; T Torigoe; J C Reed; Michael P Bell; David J McKean; Paul J Leibson; Robert T Abraham
Effects of p56lck deficiency on the growth and cytolytic effector function of an interleukin-2-dependent cytotoxic T-cell line.
Molecular and cellular biology 1992;12(10):4521-30.
1991: B N Beck; A E Nilson; Michael P Bell; C G Chase; David J McKean
The contribution of beta-strand residues to serologic epitopes on the A beta k polypeptide.
Immunogenetics 1991;33(5-6):409-12.
1990: J J Ruegemer; S N Ho; J A Augustine; J W Schlager; Michael P Bell; David J McKean; Robert T Abraham
Regulatory effects of transforming growth factor-beta on IL-2- and IL-4-dependent T cell-cycle progression.
Journal of immunology (Baltimore, Md. : 1950) 1990;144(5):1767-76.
1989: R M Ten; Larry R Pease; David J McKean; Michael P Bell; G J Gleich
Molecular cloning of the human eosinophil peroxidase. Evidence for the existence of a peroxidase multigene family.
The Journal of experimental medicine 1989;169(5):1757-69.
1989: J M Buerstedde; A E Nilson; C G Chase; Michael P Bell; B N Beck; Larry R Pease; David J McKean
A beta polymorphic residues responsible for class II molecule recognition by alloreactive T cells.
The Journal of experimental medicine 1989;169(5):1645-54.
1988: T L Wasmoen; Michael P Bell; David Loegering; G J Gleich; F G Prendergast; David J McKean
Biochemical and amino acid sequence analysis of human eosinophil granule major basic protein.
The Journal of biological chemistry 1988;263(25):12559-63.
1988: J M Buerstedde; Larry R Pease; A E Nilson; Michael P Bell; C Chase; G Buerstedde; David J McKean
Regulation of murine MHC class II molecule expression. Identification of A beta residues responsible for allele-specific cell surface expression.
The Journal of experimental medicine 1988;168(3):823-37.
1988: J M Buerstedde; Larry R Pease; Michael P Bell; A E Nilson; G Buerstedde; D Murphy; David J McKean
Identification of an immunodominant region on the I-A beta chain using site-directed mutagenesis and DNA-mediated gene transfer.
The Journal of experimental medicine 1988;167(2):473-87.
1988: James L. Borke; R D Litwiller; Michael P Bell; D N Fass; D J McKean; Rajiv Kumar
The isolation, characterization and amino terminal sequence of the vitamin D-binding protein (group specific component) from mouse plasma.
The International journal of biochemistry 1988;20(12):1343-9.
1987: B N Beck; Larry R Pease; Michael P Bell; J M Buerstedde; A E Nilson; G G Schlauder; David J McKean
DNA sequence analysis of I-Ak beta mutants reveals serologically immunodominant region.
The Journal of experimental medicine 1987;166(2):433-43.
1986: G J Gleich; David Loegering; Michael P Bell; J L Checkel; Steven J Ackerman; David J McKean
Biochemical and functional similarities between human eosinophil-derived neurotoxin and eosinophil cationic protein: homology with ribonuclease.
Proceedings of the National Academy of Sciences of the United States of America 1986;83(10):3146-50.
1985: G G Schlauder; Michael P Bell; B N Beck; A Nilson; David J McKean
The structure-function relationship of I-A molecules: a biochemical analysis of I-A polypeptides from mutant antigen-presenting cells and evidence of preferential association of allelic forms.
Journal of immunology (Baltimore, Md. : 1950) 1985;135(3):1945-54.
1985: G G Schlauder; Michael P Bell; William Paul; L H Glimcher; David J McKean
Biochemical characterization of I-Ak proteins from mutant antigen-presenting B-cell--B-lymphoma hybridomas.
Molecular immunology 1985;22(5):597-607.